Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal Transplantation

NCT01276834 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped insufficient patients enrolled

Conditions

Renal Transplantation

Interventions

DRUG: everolimus

Sponsor

Dianet Dialysis Centers

Collaborators

[object Object]